Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06995261Recruiting

Follitropin Delta in Long GnRH-agonist Protocol

Role: collaborator

NCT02097693Completed

Effect of DBS on Quality of Life in Dyskinetic Cerebral Palsy

Role: collaborator

NCT06493994Recruiting

Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry

Role: collaborator

NCT05665140Phase 2Recruiting

Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients

Role: lead

NCT02737150Not ApplicableUnknown

SecOnd-generation seLf-expandable Versus Balloon-expandable Valves and gEneral Versus Local Anesthesia in TAVI

Role: collaborator

NCT04408339Unknown

COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking

Role: collaborator

All 6 trials loaded